InvestorsHub Logo
Followers 85
Posts 314
Boards Moderated 0
Alias Born 06/20/2020

Re: Timing101 post# 44665

Thursday, 11/19/2020 4:46:22 PM

Thursday, November 19, 2020 4:46:22 PM

Post# of 198618
Great Posts Timing101. Always enjoy reading them and get something useful out of it.

To piggy-back on your post, its important to note that Charles also has a FIDUCIARY DUTY (legal obligation) to Enzolytics Inc. shareholders (us) to maximize value.

When Charles became CEO of ENZC, his fiduciary duties to ENZC shareholders kicked in. This is one of the reasons it was so important when Charles was named CEO of ENZC BEFORE the merger was completed.

As an attorney, Charles is aware of the fiduciary duty that CEOs have to their shareholders; therefore, I don't envision a scenario where ENZC shares would lose value in the merger. In fact, its the opposite and we will see PPS skyrocket to catch up to actual valuation of the merged company.


The $1.5M in notes from BioClonetics shareholders should not have any type of material impact on ENZC PPS. Hell, I've seen ENZC trade $6M in just one day.

The way this has traded over the past couple of months, I think we're in for a major ride North.

Minimum 5x (which would put Market Cap at a conservative $150M, especially after BioClonetics was valued at $127M by Navigant in 2017).

But I'm thinking more like 10-20+ times current PPS because BCLS has reached additional milestones, we have Covid pipeline in the works now (which they obviously did not in 2017 when valued at $127M) and ENZC brings a ton of value with ITV-1.

Holding & Adding. GLTA.

https://www.nolo.com/legal-encyclopedia/fiduciary-responsibility-corporations.html